Device Trial Radar · NCT02918942
Tympanoseal (Tympanic Membrane Device) Clinical Study
Last checked: Nov 20, 2026Latest source record: Oct 15, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
25
Actual
Start
Oct 4, 2016
Primary completion
Sep 30, 2021
Study completion Sep 30, 2021
Sponsor
- Lead sponsor
- Grace Medical, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 29, 2016
Design
- Study type
- Interventional
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 2 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this investigational study is to assess the ability of Tympanoseal (sodium/calcium alginate), an investigational device, to act as a scaffold during healing of the tympanic membrane. Tympanoseal is intended for use following removal or extrusion of indwelling tympanostomy tubes or traumatic injury of the tympanic membrane.
Conditions
- Tympanic Membrane Perforation
Interventions
TympanosealDevice
All subjects will receive the Tympanoseal device that will be placed during a surgical procedure.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Serious Adverse EventsTime frame: 16 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
UT Southwestern Medical Center
Plano, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.